{"id":427548,"date":"2026-02-15T20:22:20","date_gmt":"2026-02-15T20:22:20","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/427548\/"},"modified":"2026-02-15T20:22:20","modified_gmt":"2026-02-15T20:22:20","slug":"oracle-wins-cms-cloud-contract-to-power-medicare-medicaid-modernization-oracle-nyseorcl","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/427548\/","title":{"rendered":"Oracle Wins CMS Cloud Contract To Power Medicare, Medicaid Modernization &#8211; Oracle (NYSE:ORCL)"},"content":{"rendered":"<p class=\"block core-block\">Oracle Corp <a class=\"ticker-link\" data-ticker=\"ORCL\" data-exchange=\"NASDAQ\" href=\"https:\/\/www.benzinga.com\/quote\/ORCL\" target=\"_blank\" rel=\"noopener nofollow\">(NASDAQ:<\/a><a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/ORCL\" target=\"_blank\" rel=\"nofollow noopener\">ORCL<\/a>) shares are trading lower Wednesday morning after initially surging in early trading after the Centers for Medicare &amp; Medicaid Services (CMS) selected Oracle Cloud Infrastructure (OCI) to host key mission-critical systems. Here\u2019s what investors <a href=\"https:\/\/www.benzinga.com\/pressreleases\/26\/02\/n50538121\/oracle-cloud-infrastructure-to-support-centers-for-medicare-and-medicaids-modernization-initiative\" target=\"_blank\" rel=\"nofollow noopener\">need to know<\/a>.<\/p>\n<p>CMS Chooses Oracle For Medicare, Medicaid Cloud Migration<\/p>\n<p class=\"block core-block\">The federal health agency will shift select on-premises workloads to OCI as part of an IT modernization effort, leaning on Oracle&#8217;s FedRAMP High-authorized cloud to meet strict federal security and compliance requirements.<\/p>\n<p class=\"block core-block\">According to the company, OCI is expected to provide CMS with improved performance and scalability, cost efficiencies from consolidating systems and access to integrated analytics and AI tools that can support data-driven decision making and automation initiatives.<\/p>\n<p class=\"block core-block\">Oracle will also supply migration planning and technical support as CMS transitions workloads to the new environment.<\/p>\n<p>ORCL Stock Bounces Around After CMS Cloud Deal<\/p>\n<p class=\"block core-block\">The CMS win adds to Oracle&#8217;s growing roster of U.S. federal cloud customers and underscores its push to compete more actively with rivals in government infrastructure deals. Oracle shares initially moved significantly higher following the announcement. Shares have traded within a range of $163.66 to $155.55 on Wednesday.<\/p>\n<p>Technical Indicators Signal Mixed Momentum<\/p>\n<p class=\"block core-block\">Currently, Oracle is trading 5.6% below its 20-day simple moving average (SMA) and 29.2% below its 100-day SMA, demonstrating longer-term weakness. Shares have decreased 9.37% over the past 12 months and are positioned closer to their 52-week lows than highs.<\/p>\n<p class=\"block core-block\">The RSI is at 42.31, which is considered neutral territory. Meanwhile, MACD is below its signal line, indicating bearish pressure on the stock.<\/p>\n<p class=\"block core-block\">The combination of neutral RSI and bearish MACD suggests mixed momentum.<\/p>\n<p>Key Resistance: $163.50<\/p>\n<p>Key Support: $154.50<br \/>\nOracle\u2019s Business Model<\/p>\n<p class=\"block core-block\">Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. <\/p>\n<p class=\"block core-block\">Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world\u2019s largest companies for high-volume online transaction processing workloads.<\/p>\n<p class=\"block core-block\">The company plays a significant role in the software industry, especially as businesses increasingly rely on cloud solutions and AI technologies.<\/p>\n<p class=\"block core-block\">Analyst Consensus &amp; Recent Actions:\u00a0The stock carries a\u00a0Buy\u00a0Rating with an\u00a0<a href=\"https:\/\/www.benzinga.com\/quote\/ORCL\/analyst-ratings\" target=\"_blank\" rel=\"nofollow noopener\">average price target<\/a>\u00a0of\u00a0$297.36. Recent analyst moves include:<\/p>\n<p>DA Davidson: Upgraded to Buy (Maintains Target to $180.00) (Feb. 9)<\/p>\n<p>Citizens: Market Outperform (Lowers Target to $285.00) (Feb. 5)<\/p>\n<p>Scotiabank: Sector Outperform (Lowers Target to $220.00) (Feb. 3)<\/p>\n<p class=\"block core-block\">Valuation Insight:\u00a0While the stock trades at a premium P\/E multiple, the strong consensus and rising estimates suggest analysts view the growth prospects as justification for the 87% upside to analyst targets.<\/p>\n<p>Benzinga Edge Rankings<\/p>\n<p class=\"block core-block\">Below is the\u00a0<a href=\"https:\/\/www.benzinga.com\/screener\" target=\"_blank\" rel=\"nofollow noopener\">Benzinga Edge scorecard<\/a>\u00a0for Oracle, highlighting its strengths and weaknesses compared to the broader market:<\/p>\n<p>Value: Weak (Score: 16.11) \u2014 Trading at a steep premium relative to peers.<\/p>\n<p>Momentum: Weak (Score: 8.93) \u2014 Stock is underperforming the broader market.<\/p>\n<p class=\"block core-block\">The Verdict:\u00a0Oracle\u2019s Benzinga Edge signal reveals a challenging landscape, with weak momentum and value scores indicating potential headwinds. Investors should be cautious as the stock navigates through a mixed technical environment.<\/p>\n<p>ORCL Shares Trade Flat Wednesday<\/p>\n<p class=\"block core-block\">ORCL Price Action:\u00a0Oracle shares were down 2.61% at $155.75 at the time of publication on Wednesday, according to <a href=\"https:\/\/pro.benzinga.com\/dashboard\" target=\"_blank\" rel=\"nofollow noopener\">Benzinga Pro data<\/a>.<\/p>\n<p class=\"block core-block\">Image: Shutterstock<\/p>\n","protected":false},"excerpt":{"rendered":"Oracle Corp (NASDAQ:ORCL) shares are trading lower Wednesday morning after initially surging in early trading after the Centers&hellip;\n","protected":false},"author":2,"featured_media":427549,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[156778,7898,7897,102,2960,7896,156779,156780,156781,56,54,55],"class_list":["post-427548","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-category-movers","tag-category-news","tag-cms-wordpress","tag-health","tag-healthcare","tag-pageisbzpro-bz","tag-symbol-orcl","tag-tag-benzai","tag-tag-why-its-moving","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/427548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=427548"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/427548\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/427549"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=427548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=427548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=427548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}